Seizure worsening caused by low serum valproate levels from an interaction between valproate and meropenem

Authors : Suat BİÇER, Gülay ÇİLER ERDAĞ, Canan KOCAMAN YILDIRIM, Tuba GİRAY, Defne ÇÖL, Öznur KÜÇÜK, Zerrin YALVAÇ, Ayça VİTRİNEL

Pages : 116-119

Doi:10.5472/MMJcr.2802.12

View : 40 | Download : 6

Publication Date : 2015-09-14

Article Type : Other Papers

Abstract :We present an interaction of meropenem with valproate in an epileptic child, leading to seizure exacerbations owing to the rapid lowering of serum valproate concentration. An increase of seizure frequency and somnolence were observed in the patient after the addition of meropenem to the treatment, and a rapid decline of valproate serum concentrations was observed after two doses of meropenem. This decline was the most likely cause of the increase in seizure frequency. The dosage of valproate was raised and meropenem was stopped. Two days later, the seizures stopped. Five days later, the serum valproate concentrations raised to three fold, and they rose to therapeutic levels four weeks later. To avoid drug interaction that reduces the serum concentration of valproate, meropenem in epileptic patients using valproate for the treatment of epilepsy should be administered cautiously. If concominant administration is essential, close observation of serum concentration of valproate and clinical course of the patient are necessary. Keywords: Carbapenems, Drug interactions, Meropenem, Seizures, Valproate
Keywords :

ORIGINAL ARTICLE URL